Description
Rituximab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Rituximab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary)